Sun Pharma to introduce molnupiravir in India
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Evidence also shows better immune response to virus among users of spray
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The students can interact with resident doctors and graduates of SGU
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Both parties are expected to invest a total of US $ 1 million to establish the brand
The NFI is published to promote the rational use of medicines in the country.
Subscribe To Our Newsletter & Stay Updated